Vyjuvek Gets FDA Nod as First Topical Gene Therapy for Rare Skin Disease
XTalks
MAY 26, 2023
DEB patients are also at an increased risk of aggressive skin cancer.DEB usually presents at birth and is caused by one or more mutations in the COL7A1 gene, which encodes type VII collagen (COL7), an important protein that helps connect, strengthen and stabilize the outer and middle layers of the skin.
Let's personalize your content